334 related articles for article (PubMed ID: 33783998)
1. Emerging roles of the solute carrier family in pancreatic cancer.
Wu Z; Xu J; Liang C; Meng Q; Hua J; Wang W; Zhang B; Liu J; Yu X; Shi S
Clin Transl Med; 2021 Mar; 11(3):e356. PubMed ID: 33783998
[TBL] [Abstract][Full Text] [Related]
2. Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy.
Hushmandi K; Einollahi B; Saadat SH; Lee EHC; Farani MR; Okina E; Huh YS; Nabavi N; Salimimoghadam S; Kumar AP
Mol Metab; 2024 Jun; 84():101952. PubMed ID: 38705513
[TBL] [Abstract][Full Text] [Related]
3. Role of solute carrier transporters in regulating dendritic cell maturation and function.
Shao L; Yang M; Sun T; Xia H; Du D; Li X; Jie Z
Eur J Immunol; 2024 Feb; 54(2):e2350385. PubMed ID: 38073515
[TBL] [Abstract][Full Text] [Related]
4. Targeting SLC transporters: small molecules as modulators and therapeutic opportunities.
Schlessinger A; Zatorski N; Hutchinson K; Colas C
Trends Biochem Sci; 2023 Sep; 48(9):801-814. PubMed ID: 37355450
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a novel microscale thermophoresis ligand-binding assay for characterization of SLC solute carriers using oligopeptide transporter PepT1 (SLC15 family) as a model system.
Clémençon B; Lüscher BP; Hediger MA
J Pharmacol Toxicol Methods; 2018; 92():67-76. PubMed ID: 29580877
[TBL] [Abstract][Full Text] [Related]
6. Impact of Solute Carrier Transporters in Glioma Pathology: A Comprehensive Review.
Anagnostakis F; Kokkorakis M; Markouli M; Piperi C
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298344
[TBL] [Abstract][Full Text] [Related]
7. Advances and Challenges in Rational Drug Design for SLCs.
Garibsingh RA; Schlessinger A
Trends Pharmacol Sci; 2019 Oct; 40(10):790-800. PubMed ID: 31519459
[TBL] [Abstract][Full Text] [Related]
8. Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic Disease.
Schumann T; König J; Henke C; Willmes DM; Bornstein SR; Jordan J; Fromm MF; Birkenfeld AL
Pharmacol Rev; 2020 Jan; 72(1):343-379. PubMed ID: 31882442
[TBL] [Abstract][Full Text] [Related]
9. Recent developments in ligands and chemical probes targeting solute carrier transporters.
Casiraghi A; Bensimon A; Superti-Furga G
Curr Opin Chem Biol; 2021 Jun; 62():53-63. PubMed ID: 33689964
[TBL] [Abstract][Full Text] [Related]
10. A phylogenetic analysis between humans and D. melanogaster: A repertoire of solute carriers in humans and flies.
Ceder MM; Fredriksson R
Gene; 2022 Jan; 809():146033. PubMed ID: 34673204
[TBL] [Abstract][Full Text] [Related]
11. Membrane transporters in cell physiology, cancer metabolism and drug response.
Alam S; Doherty E; Ortega-Prieto P; Arizanova J; Fets L
Dis Model Mech; 2023 Nov; 16(11):. PubMed ID: 38037877
[TBL] [Abstract][Full Text] [Related]
12. The Druggability of Solute Carriers.
Wang WW; Gallo L; Jadhav A; Hawkins R; Parker CG
J Med Chem; 2020 Apr; 63(8):3834-3867. PubMed ID: 31774679
[TBL] [Abstract][Full Text] [Related]
13. Harnessing Solute Carrier Transporters for Precision Oncology.
Nyquist MD; Prasad B; Mostaghel EA
Molecules; 2017 Mar; 22(4):. PubMed ID: 28350329
[TBL] [Abstract][Full Text] [Related]
14. The association between the expression of solute carrier transporters and the prognosis of pancreatic cancer.
Mohelnikova-Duchonova B; Brynychova V; Hlavac V; Kocik M; Oliverius M; Hlavsa J; Honsova E; Mazanec J; Kala Z; Melichar B; Soucek P
Cancer Chemother Pharmacol; 2013 Sep; 72(3):669-82. PubMed ID: 23934321
[TBL] [Abstract][Full Text] [Related]
15. A widespread role for SLC transmembrane transporters in resistance to cytotoxic drugs.
Girardi E; César-Razquin A; Lindinger S; Papakostas K; Konecka J; Hemmerich J; Kickinger S; Kartnig F; Gürtl B; Klavins K; Sedlyarov V; Ingles-Prieto A; Fiume G; Koren A; Lardeau CH; Kumaran Kandasamy R; Kubicek S; Ecker GF; Superti-Furga G
Nat Chem Biol; 2020 Apr; 16(4):469-478. PubMed ID: 32152546
[TBL] [Abstract][Full Text] [Related]
16. Rational exploration of fold atlas for human solute carrier proteins.
Xie T; Chi X; Huang B; Ye F; Zhou Q; Huang J
Structure; 2022 Sep; 30(9):1321-1330.e5. PubMed ID: 35700727
[TBL] [Abstract][Full Text] [Related]
17. Targeting solute carriers to modulate receptor-ligand interactions.
Sijben HJ; Superti-Furga G; IJzerman AP; Heitman LH
Trends Pharmacol Sci; 2022 May; 43(5):358-361. PubMed ID: 35232590
[TBL] [Abstract][Full Text] [Related]
18. The fruit fly Drosophila melanogaster as an innovative preclinical ADME model for solute carrier membrane transporters, with consequences for pharmacology and drug therapy.
Wang Y; Moussian B; Schaeffeler E; Schwab M; Nies AT
Drug Discov Today; 2018 Oct; 23(10):1746-1760. PubMed ID: 29890226
[TBL] [Abstract][Full Text] [Related]
19. Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance.
Ram Makena M; Gatla H; Verlekar D; Sukhavasi S; K Pandey M; C Pramanik K
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31480221
[TBL] [Abstract][Full Text] [Related]
20. Welcome to the Family: Identification of the NAD
Ziegler M; Monné M; Nikiforov A; Agrimi G; Heiland I; Palmieri F
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34198503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
